| Primary |
| Asthma |
55.6% |
| Chronic Obstructive Pulmonary Disease |
22.2% |
| Hypertension |
7.4% |
| Productive Cough |
7.4% |
| Hypercholesterolaemia |
3.7% |
| Product Used For Unknown Indication |
3.7% |
|
| Dyspnoea |
11.1% |
| Myocardial Infarction |
11.1% |
| Respiratory Failure |
11.1% |
| Chest Pain |
5.6% |
| Cyanosis Central |
5.6% |
| Drug Interaction |
5.6% |
| Epilepsy |
5.6% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
5.6% |
| Oral Candidiasis |
5.6% |
| Pneumonia |
5.6% |
| Productive Cough |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
| Unresponsive To Stimuli |
5.6% |
| Ventricular Fibrillation |
5.6% |
| Wheezing |
5.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.6% |
| Chronic Obstructive Pulmonary Disease |
12.0% |
| Asthma |
10.6% |
| Depression |
5.3% |
| Emphysema |
4.3% |
| Dermatitis |
4.0% |
| Thrombosis Prophylaxis |
4.0% |
| Atrial Fibrillation |
3.7% |
| Epilepsy |
3.7% |
| Product Used For Unknown Indication |
3.3% |
| Grand Mal Convulsion |
3.0% |
| Tachycardia Paroxysmal |
3.0% |
| Sleep Disorder |
2.7% |
| Pain |
2.0% |
| Arrhythmia |
1.7% |
| Essential Hypertension |
1.7% |
| Pyrexia |
1.7% |
| Conjunctivitis |
1.3% |
| Cytomegalovirus Chorioretinitis |
1.3% |
| Diarrhoea |
1.3% |
|
| Neuroleptic Malignant Syndrome |
17.5% |
| Tonic Convulsion |
10.0% |
| Toxic Epidermal Necrolysis |
10.0% |
| Asthma |
7.5% |
| Diarrhoea |
7.5% |
| Epilepsy |
5.0% |
| Pseudomonas Infection |
5.0% |
| Thrombocytopenia |
5.0% |
| Visual Impairment |
5.0% |
| Allergic Granulomatous Angiitis |
2.5% |
| Condition Aggravated |
2.5% |
| Constipation |
2.5% |
| Drug Ineffective |
2.5% |
| Gastrointestinal Haemorrhage |
2.5% |
| Haemorrhage |
2.5% |
| Hypertension |
2.5% |
| Lethargy |
2.5% |
| Musculoskeletal Stiffness |
2.5% |
| Orthostatic Hypotension |
2.5% |
| Photosensitivity Reaction |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.9% |
| Asthma |
18.9% |
| Chronic Obstructive Pulmonary Disease |
7.9% |
| Hypertension |
6.5% |
| Hiv Infection |
5.4% |
| Diffuse Panbronchiolitis |
5.3% |
| Product Used For Unknown Indication |
4.9% |
| Emphysema |
3.6% |
| Rheumatoid Arthritis |
3.2% |
| Diabetes Mellitus |
1.9% |
| Constipation |
1.7% |
| Depression |
1.4% |
| Antiviral Prophylaxis |
1.3% |
| Chronic Respiratory Failure |
1.3% |
| Hyperlipidaemia |
1.2% |
| Procedural Pain |
1.2% |
| Arthritis |
1.1% |
| Duodenal Ulcer |
1.1% |
| Induction Of Anaesthesia |
1.1% |
| Insomnia |
1.1% |
|
| White Blood Cell Count Increased |
10.2% |
| Sepsis |
7.4% |
| Pyrexia |
6.5% |
| Vomiting |
6.5% |
| Asthma |
5.6% |
| Dyspnoea |
5.6% |
| Osteoporosis |
5.6% |
| Overdose |
4.6% |
| Prescribed Overdose |
4.6% |
| Syncope |
4.6% |
| Vasculitis |
4.6% |
| Ventricular Tachycardia |
4.6% |
| Drug Ineffective |
3.7% |
| Haemoptysis |
3.7% |
| Interstitial Lung Disease |
3.7% |
| Mental Status Changes |
3.7% |
| Myositis |
3.7% |
| Oxygen Saturation Decreased |
3.7% |
| Peritonsillar Abscess |
3.7% |
| Sputum Retention |
3.7% |
|
